Protalix BioTherapeutics Inc (PLX)
1.11
-0.14
(-11.20%)
USD |
NYAM |
May 10, 16:00
1.11
0.00 (0.00%)
After-Hours: 18:13
Protalix BioTherapeutics Total Assets (Quarterly): 84.43M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 84.43M |
| September 30, 2023 | 87.57M |
| June 30, 2023 | 88.42M |
| March 31, 2023 | 66.56M |
| December 31, 2022 | 55.79M |
| September 30, 2022 | 56.71M |
| June 30, 2022 | 60.64M |
| March 31, 2022 | 68.39M |
| December 31, 2021 | 73.66M |
| September 30, 2021 | 83.48M |
| June 30, 2021 | 108.20M |
| March 31, 2021 | 102.79M |
| December 31, 2020 | 67.93M |
| September 30, 2020 | 72.31M |
| June 30, 2020 | 71.71M |
| March 31, 2020 | 82.88M |
| December 31, 2019 | 45.39M |
| September 30, 2019 | 53.73M |
| June 30, 2019 | 55.24M |
| March 31, 2019 | 61.04M |
| December 31, 2018 | 61.13M |
| September 30, 2018 | 67.20M |
| June 30, 2018 | 51.72M |
| March 31, 2018 | 64.80M |
| December 31, 2017 | 72.21M |
| Date | Value |
|---|---|
| September 30, 2017 | 61.06M |
| June 30, 2017 | 59.00M |
| March 31, 2017 | 71.85M |
| December 31, 2016 | 82.25M |
| September 30, 2016 | 70.47M |
| June 30, 2016 | 78.86M |
| March 31, 2016 | 87.31M |
| December 31, 2015 | 97.25M |
| September 30, 2015 | 59.49M |
| June 30, 2015 | 65.95M |
| March 31, 2015 | 72.05M |
| December 31, 2014 | 78.36M |
| September 30, 2014 | 84.80M |
| June 30, 2014 | 96.65M |
| March 31, 2014 | 103.42M |
| December 31, 2013 | 113.33M |
| September 30, 2013 | 121.16M |
| June 30, 2013 | 62.31M |
| March 31, 2013 | 69.94M |
| December 31, 2012 | 78.73M |
| September 30, 2012 | 77.38M |
| June 30, 2012 | 84.30M |
| March 31, 2012 | 68.46M |
| December 31, 2011 | 51.80M |
| September 30, 2011 | 60.83M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
45.39M
Minimum
Dec 2019
108.20M
Maximum
Jun 2021
72.94M
Average
71.71M
Median
Jun 2020
Total Assets (Quarterly) Benchmarks
| Agenus Inc | 313.91M |
| InfuSystems Holdings Inc | 102.92M |
| AIM ImmunoTech Inc | 19.38M |
| Perspective Therapeutics Inc | 97.89M |
| Armata Pharmaceuticals Inc | 98.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 50.86M |
| Shareholders Equity (Quarterly) | 33.57M |
| Debt to Equity Ratio | 0.6033 |
| Current Ratio | 1.536 |
| Net Debt Paydown Yield | 1.21% |